These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31905966)

  • 121. [Immunotherapy and non-small cell lung cancer : a (r)evolution].
    Berghmans T; Meert AP
    Rev Med Brux; 2017; 38(3):175-177. PubMed ID: 28653522
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Understanding the checkpoint blockade in lung cancer immunotherapy.
    Dal Bello MG; Alama A; Coco S; Vanni I; Grossi F
    Drug Discov Today; 2017 Aug; 22(8):1266-1273. PubMed ID: 28600190
    [TBL] [Abstract][Full Text] [Related]  

  • 123. EGFR TKI combination with immunotherapy in non-small cell lung cancer.
    Ahn MJ; Sun JM; Lee SH; Ahn JS; Park K
    Expert Opin Drug Saf; 2017 Apr; 16(4):465-469. PubMed ID: 28271729
    [TBL] [Abstract][Full Text] [Related]  

  • 124. FAK-inhibition opens the door to checkpoint immunotherapy in Pancreatic Cancer.
    Symeonides SN; Anderton SM; Serrels A
    J Immunother Cancer; 2017; 5():17. PubMed ID: 28239470
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines?
    Guillon A; Reckamp KL; Heuzé-Vourc'h N
    Crit Care; 2017 Jan; 21(1):18. PubMed ID: 28126007
    [No Abstract]   [Full Text] [Related]  

  • 126. Potential role of immunotherapy in advanced non-small-cell lung cancer.
    de Mello RA; Veloso AF; Esrom Catarina P; Nadine S; Antoniou G
    Onco Targets Ther; 2017; 10():21-30. PubMed ID: 28031719
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Immunotherapy in Lung Cancer.
    Du L; Herbst RS; Morgensztern D
    Hematol Oncol Clin North Am; 2017 Feb; 31(1):131-141. PubMed ID: 27912829
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells.
    Gammaitoni L; Giraudo L; Macagno M; Leuci V; Mesiano G; Rotolo R; Sassi F; Sanlorenzo M; Zaccagna A; Pisacane A; Senetta R; Cangemi M; Cattaneo G; Martin V; Coha V; Gallo S; Pignochino Y; Sapino A; Grignani G; Carnevale-Schianca F; Aglietta M; Sangiolo D
    Clin Cancer Res; 2017 May; 23(9):2277-2288. PubMed ID: 27815354
    [No Abstract]   [Full Text] [Related]  

  • 129. Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse.
    Nardone V; Botta C; Caraglia M; Martino EC; Ambrosio MR; Carfagno T; Tini P; Semeraro L; Misso G; Grimaldi A; Boccellino M; Facchini G; Berretta M; Vischi G; Rocca BJ; Barone A; Tassone P; Tagliaferri P; Del Vecchio MT; Pirtoli L; Correale P
    Cancer Biol Ther; 2016 Nov; 17(11):1213-1220. PubMed ID: 27791459
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Therapeutic outcomes of autologous CIK cells as a maintenance therapy in the treatment of lung cancer patients: A retrospective study.
    Luo H; Gong L; Zhu B; Huang Y; Tang C; Yu S; Yang Z; Zhou X
    Biomed Pharmacother; 2016 Dec; 84():987-993. PubMed ID: 27764762
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Tumor infiltrating lymphocytes in lung cancer: a new prognostic parameter.
    Reynders K; De Ruysscher D
    J Thorac Dis; 2016 Aug; 8(8):E833-5. PubMed ID: 27618931
    [No Abstract]   [Full Text] [Related]  

  • 132. β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer.
    Yin HL; Wu CC; Lin CH; Chai CY; Hou MF; Chang SJ; Tsai HP; Hung WC; Pan MR; Luo CW
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589736
    [TBL] [Abstract][Full Text] [Related]  

  • 133. PD-L1 expression in human cancers and its association with clinical outcomes.
    Wang X; Teng F; Kong L; Yu J
    Onco Targets Ther; 2016; 9():5023-39. PubMed ID: 27574444
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Pancreatic cancer: FAK regulates sensitivity to immunotherapy.
    Sidaway P
    Nat Rev Clin Oncol; 2016 Sep; 13(9):528. PubMed ID: 27430749
    [No Abstract]   [Full Text] [Related]  

  • 135. Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.
    Jiang H; Hegde S; Knolhoff BL; Zhu Y; Herndon JM; Meyer MA; Nywening TM; Hawkins WG; Shapiro IM; Weaver DT; Pachter JA; Wang-Gillam A; DeNardo DG
    Nat Med; 2016 Aug; 22(8):851-60. PubMed ID: 27376576
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival.
    Oelsner S; Wagner J; Friede ME; Pfirrmann V; Genßler S; Rettinger E; Buchholz CJ; Pfeifer H; Schubert R; Ottmann OG; Ullrich E; Bader P; Wels WS
    Int J Cancer; 2016 Oct; 139(8):1799-809. PubMed ID: 27253354
    [TBL] [Abstract][Full Text] [Related]  

  • 137. FAK goes nuclear to control antitumor immunity-a new target in cancer immuno-therapy.
    Serrels A; Frame MC
    Oncoimmunology; 2016 Apr; 5(4):e1119356. PubMed ID: 27141405
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Implication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer.
    Dai C; Lin F; Geng R; Ge X; Tang W; Chang J; Wu Z; Liu X; Lin Y; Zhang Z; Li J
    Oncotarget; 2016 Mar; 7(9):10332-44. PubMed ID: 26871284
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
    Agarwal G; Nanda G; Lal P; Mishra A; Agarwal A; Agrawal V; Krishnani N
    World J Surg; 2016 Jun; 40(6):1362-72. PubMed ID: 26842691
    [TBL] [Abstract][Full Text] [Related]  

  • 140. The fate of chemoresistance in triple negative breast cancer (TNBC).
    O'Reilly EA; Gubbins L; Sharma S; Tully R; Guang MH; Weiner-Gorzel K; McCaffrey J; Harrison M; Furlong F; Kell M; McCann A
    BBA Clin; 2015 Jun; 3():257-75. PubMed ID: 26676166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.